Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johns Hopkins Bloomberg School of Public Health
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Tufts Medical Center
The present study was conducted in order to: 1) quantify the metabolomic expression of dietary intake; and 2) examine the relationship between metabolites that reflect dietary intake and kidney disease progression. This secondary data analysis leverages the completed Modification of Diet in Renal Disease (MDRD) study, a randomized clinical trial of dietary protein restriction (N=840).
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18-70
Evidence of chronic renal disease with increased serum creatinine (men: 1.4-7.0 mg/dL, women: 1.2-7.0 mg/dL)
Mean arterial blood pressure less than or equal to 125 mmHg
You may not be if
Insulin-dependent diabetes
Kidney transplant recipient
Clareo Health | Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression
